- Home
- TURN vs NOTV Comparison
TURN vs NOTV Comparison
Compare TURN & NOTV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TURN
- NOTV
- Stock Information
- Founded
- TURN 1981
- NOTV 1974
- Country
- TURN United States
- NOTV United States
- Employees
- TURN 8
- NOTV N/A
- Industry
- TURN Finance/Investors Services
- NOTV Biotechnology: Pharmaceutical Preparations
- Sector
- TURN Finance
- NOTV Health Care
- Exchange
- TURN Nasdaq
- NOTV Nasdaq
- Market Cap
- TURN 49.6M
- NOTV 57.7M
- IPO Year
- TURN N/A
- NOTV 1997
- Fundamental
- Price
- TURN $4.96
- NOTV $1.39
- Analyst Decision
- TURN
- NOTV Strong Buy
- Analyst Count
- TURN 0
- NOTV 1
- Target Price
- TURN N/A
- NOTV $5.00
- AVG Volume (30 Days)
- TURN 33.1K
- NOTV 395.3K
- Earning Date
- TURN 02-26-2018
- NOTV 08-06-2025
- Dividend Yield
- TURN N/A
- NOTV N/A
- EPS Growth
- TURN N/A
- NOTV N/A
- EPS
- TURN 0.29
- NOTV N/A
- Revenue
- TURN $488,011.00
- NOTV $505,299,000.00
- Revenue This Year
- TURN N/A
- NOTV $5.64
- Revenue Next Year
- TURN N/A
- NOTV $5.16
- P/E Ratio
- TURN $17.34
- NOTV N/A
- Revenue Growth
- TURN 277.43
- NOTV 0.85
- 52 Week Low
- TURN $3.12
- NOTV $1.15
- 52 Week High
- TURN $5.01
- NOTV $6.48
- Technical
- Relative Strength Index (RSI)
- TURN 67.09
- NOTV 33.81
- Support Level
- TURN $4.51
- NOTV $1.36
- Resistance Level
- TURN $4.90
- NOTV $1.68
- Average True Range (ATR)
- TURN 0.17
- NOTV 0.11
- MACD
- TURN -0.01
- NOTV -0.02
- Stochastic Oscillator
- TURN 90.00
- NOTV 9.00
About TURN 180 Degree Capital Corp.
180 Degree Capital Corp is active in the financial services domain. It is a non-diversified closed-end management investment company whose objective is to achieve long-term capital appreciation by making venture capital investments. It focuses its investments on companies commercializing and integrating products enabled by disruptive technologies mainly in the life sciences, precision medicine, and health industries.
About NOTV Inotiv Inc.
Inotiv Inc is a pharmaceutical development company specializing in nonclinical and analytical drug discovery, development services to the pharmaceutical, chemical, and medical device industries. It operates in two segments; Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). Through the DSA segment, the company supports the discovery, nonclinical development, and clinical development needs of researchers and clinicians for small molecule drug candidates, biotherapeutics, and biomedical devices. Through the RMS segment, the company offers access to a wide range of small and large research models for basic research, drug discovery, development, and specialized models for specific diseases and therapeutic areas. The company earns maximum revenue from RMS Segment.